A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Summary

To evaluate the efficacy and safety of Levetiracetam dry syrup at doses up to 60 mg/kg/day or 3000 mg/day used as adjunctive therapy in Japanese pediatric patients aged ≥4 to \<16 years with uncontrolled Generalized Tonic-Clonic (GTC) seizures despite treatment with 1 or 2 Anti-Epileptic Drugs (AEDs).

Timeline

Start

2011-02

Primary completion

2013-06

Completion

2013-06

Drugs

Indications